S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version

Standard

S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version. / Batra, Anil; Kiefer, Falk; Andreas, Stefan; Gohlke, Helmut; Klein, Marianne; Kotz, Daniel; Mons, Ute; Mühlig, Stephan; Pötschke-Langer, Martina; Preuss, Ulrich W; Rüther, Tobias; Rustler, Christa; Thomasius, Rainer; Ulbricht, Sabina; Petersen, Kay Uwe.

In: EUR ADDICT RES, Vol. 28, No. 5, 2022, p. 382-400.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Batra, A, Kiefer, F, Andreas, S, Gohlke, H, Klein, M, Kotz, D, Mons, U, Mühlig, S, Pötschke-Langer, M, Preuss, UW, Rüther, T, Rustler, C, Thomasius, R, Ulbricht, S & Petersen, KU 2022, 'S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version', EUR ADDICT RES, vol. 28, no. 5, pp. 382-400. https://doi.org/10.1159/000525265

APA

Batra, A., Kiefer, F., Andreas, S., Gohlke, H., Klein, M., Kotz, D., Mons, U., Mühlig, S., Pötschke-Langer, M., Preuss, U. W., Rüther, T., Rustler, C., Thomasius, R., Ulbricht, S., & Petersen, K. U. (2022). S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version. EUR ADDICT RES, 28(5), 382-400. https://doi.org/10.1159/000525265

Vancouver

Bibtex

@article{9a41aa6e6b724ee3b605e3ba81a7c743,
title = "S3 Guideline {"}Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment{"} - Short Version",
abstract = "INTRODUCTION: In addition to the prevention of tobacco consumption, the establishment and assurance of high-quality treatment for harmful use and dependence on tobacco products remains an important health-related task in Germany. Regular updating of the Association of the Scientific Medical Societies (AWMF) S3 guideline {"}Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment{"} (Tobacco Guideline) offers a sustainable and reputable source of knowledge on smoking cessation.METHODS: Under the auspices of the German Society for Psychiatry, Psychotherapy, Psychosomatics, and Neurology (DGPPN) and the German Society for Addiction Research and Addiction Therapy (DG-Sucht), the Tobacco Guideline was revised in 2019-2020 by 63 experts, who were involved in the development process of the text, in 11 working groups. Undue influence of conflicts of interest on the guideline could be minimized through careful conflict of interest management. Delegates from 50 professional societies discussed the 80 guideline recommendations and voted online.RESULTS: In addition to recommendations for screening and diagnostics, the Tobacco Guideline takes a positive stance towards the use of low-threshold counseling and support services. If, due to the severity of the tobacco-related disorder, brief counseling, telephone counseling, or internet- or smartphone-based methods are not sufficiently effective, individual or group behavioral therapy, possibly in combination with medication, is indicated. If nicotine replacement therapy is not effective, varenicline or bupropion should be offered. Alternative strategies with a lower level of recommendation are hypnotherapy, mindfulness-based treatments, or medication with cytisine. In adolescents and pregnant women, the use of medication should be limited to well-specified exceptions and nicotine replacement. The mean agreement with the recommendations reached a value of 98%. A general overview of the treatment recommendations of the Tobacco Guideline is provided by three clinical algorithms.",
author = "Anil Batra and Falk Kiefer and Stefan Andreas and Helmut Gohlke and Marianne Klein and Daniel Kotz and Ute Mons and Stephan M{\"u}hlig and Martina P{\"o}tschke-Langer and Preuss, {Ulrich W} and Tobias R{\"u}ther and Christa Rustler and Rainer Thomasius and Sabina Ulbricht and Petersen, {Kay Uwe}",
note = "{\textcopyright} 2022 S. Karger AG, Basel.",
year = "2022",
doi = "10.1159/000525265",
language = "English",
volume = "28",
pages = "382--400",
journal = "EUR ADDICT RES",
issn = "1022-6877",
publisher = "S. Karger AG",
number = "5",

}

RIS

TY - JOUR

T1 - S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version

AU - Batra, Anil

AU - Kiefer, Falk

AU - Andreas, Stefan

AU - Gohlke, Helmut

AU - Klein, Marianne

AU - Kotz, Daniel

AU - Mons, Ute

AU - Mühlig, Stephan

AU - Pötschke-Langer, Martina

AU - Preuss, Ulrich W

AU - Rüther, Tobias

AU - Rustler, Christa

AU - Thomasius, Rainer

AU - Ulbricht, Sabina

AU - Petersen, Kay Uwe

N1 - © 2022 S. Karger AG, Basel.

PY - 2022

Y1 - 2022

N2 - INTRODUCTION: In addition to the prevention of tobacco consumption, the establishment and assurance of high-quality treatment for harmful use and dependence on tobacco products remains an important health-related task in Germany. Regular updating of the Association of the Scientific Medical Societies (AWMF) S3 guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" (Tobacco Guideline) offers a sustainable and reputable source of knowledge on smoking cessation.METHODS: Under the auspices of the German Society for Psychiatry, Psychotherapy, Psychosomatics, and Neurology (DGPPN) and the German Society for Addiction Research and Addiction Therapy (DG-Sucht), the Tobacco Guideline was revised in 2019-2020 by 63 experts, who were involved in the development process of the text, in 11 working groups. Undue influence of conflicts of interest on the guideline could be minimized through careful conflict of interest management. Delegates from 50 professional societies discussed the 80 guideline recommendations and voted online.RESULTS: In addition to recommendations for screening and diagnostics, the Tobacco Guideline takes a positive stance towards the use of low-threshold counseling and support services. If, due to the severity of the tobacco-related disorder, brief counseling, telephone counseling, or internet- or smartphone-based methods are not sufficiently effective, individual or group behavioral therapy, possibly in combination with medication, is indicated. If nicotine replacement therapy is not effective, varenicline or bupropion should be offered. Alternative strategies with a lower level of recommendation are hypnotherapy, mindfulness-based treatments, or medication with cytisine. In adolescents and pregnant women, the use of medication should be limited to well-specified exceptions and nicotine replacement. The mean agreement with the recommendations reached a value of 98%. A general overview of the treatment recommendations of the Tobacco Guideline is provided by three clinical algorithms.

AB - INTRODUCTION: In addition to the prevention of tobacco consumption, the establishment and assurance of high-quality treatment for harmful use and dependence on tobacco products remains an important health-related task in Germany. Regular updating of the Association of the Scientific Medical Societies (AWMF) S3 guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" (Tobacco Guideline) offers a sustainable and reputable source of knowledge on smoking cessation.METHODS: Under the auspices of the German Society for Psychiatry, Psychotherapy, Psychosomatics, and Neurology (DGPPN) and the German Society for Addiction Research and Addiction Therapy (DG-Sucht), the Tobacco Guideline was revised in 2019-2020 by 63 experts, who were involved in the development process of the text, in 11 working groups. Undue influence of conflicts of interest on the guideline could be minimized through careful conflict of interest management. Delegates from 50 professional societies discussed the 80 guideline recommendations and voted online.RESULTS: In addition to recommendations for screening and diagnostics, the Tobacco Guideline takes a positive stance towards the use of low-threshold counseling and support services. If, due to the severity of the tobacco-related disorder, brief counseling, telephone counseling, or internet- or smartphone-based methods are not sufficiently effective, individual or group behavioral therapy, possibly in combination with medication, is indicated. If nicotine replacement therapy is not effective, varenicline or bupropion should be offered. Alternative strategies with a lower level of recommendation are hypnotherapy, mindfulness-based treatments, or medication with cytisine. In adolescents and pregnant women, the use of medication should be limited to well-specified exceptions and nicotine replacement. The mean agreement with the recommendations reached a value of 98%. A general overview of the treatment recommendations of the Tobacco Guideline is provided by three clinical algorithms.

U2 - 10.1159/000525265

DO - 10.1159/000525265

M3 - SCORING: Journal article

C2 - 35760048

VL - 28

SP - 382

EP - 400

JO - EUR ADDICT RES

JF - EUR ADDICT RES

SN - 1022-6877

IS - 5

ER -